http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0381750-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd89d77edade2f51432063328b1932e6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
filingDate 1989-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98a30794e36fdf8119518461409311b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764aa0f841a81ae9f6352d9d4d3e70ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9a718c7522fe76ac429d68bc97e1a0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1676bce351f474a46964a01bb8be122f
publicationDate 1990-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0381750-A1
titleOfInvention METHOD FOR TREATING AND PREVENTING LOSS OF BONE MASS.
abstract The invention describes and claims the use of alpha-vitamin D2 as a medicament in the treatment of osteoporosis. Active vitamin D3 compounds are ineffective or have minimal efficacy at dosage levels that can be tolerated by humans. At dosage levels required in order to effectively replenish lost bone mass, active vitamin D3 compounds exhibit an amount of serious toxicity in the form of hypercalcemia and hypercalciuria. The inventors have discovered that 1alpha-vitamin D2, which is as active as 1alpha-vitamin D3 for stimulating the intestinal absorption of calcium, can be administered safely at dosages greater than 3.0 mug / day without stimulating reabsorption. bone.
priorityDate 1988-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226660079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87070941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226784137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226709463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226609040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226629325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87080434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226509607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53882689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228014970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54069760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12303103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87087721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87058084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87085754

Total number of triples: 43.